124 related articles for article (PubMed ID: 32385051)
21. Sentinel Lymph Node Mapping vs Systematic Lymphadenectomy for Endometrial Cancer: Surgical Morbidity and Lymphatic Complications.
Accorsi GS; Paiva LL; Schmidt R; Vieira M; Reis R; Andrade C
J Minim Invasive Gynecol; 2020; 27(4):938-945.e2. PubMed ID: 31421249
[TBL] [Abstract][Full Text] [Related]
22. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers.
Buda A; Di Martino G; Restaino S; De Ponti E; Monterossi G; Giuliani D; Ercoli A; Dell'Orto F; Dinoi G; Grassi T; Scambia G; Fanfani F
Gynecol Oncol; 2017 Dec; 147(3):528-534. PubMed ID: 29032824
[TBL] [Abstract][Full Text] [Related]
23. Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: Results of a retrospective multicenter study.
Raimond E; Ballester M; Hudry D; Bendifallah S; Daraï E; Graesslin O; Coutant C
Gynecol Oncol; 2014 Jun; 133(3):506-11. PubMed ID: 24642092
[TBL] [Abstract][Full Text] [Related]
24. Impact of sentinel lymph node mapping on survival in patients with high-risk endometrial cancer in the early stage: A matched cohort study.
Jaafar E; Gaultier V; Wohrer H; Estevez JP; Gonthier C; Koskas M
Int J Gynaecol Obstet; 2024 May; 165(2):677-684. PubMed ID: 38226675
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial).
Baiocchi G; Andrade CEMC; Ribeiro R; Moretti-Marques R; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Costa RLR; Kumagai LY; Badiglian-Filho L; Faloppa CC; Mantoan H; De Brot L; Dos Reis R; Goncalves BT
Int J Gynecol Cancer; 2022 May; 32(5):676-679. PubMed ID: 35236752
[TBL] [Abstract][Full Text] [Related]
26. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Plante M
Gynecol Oncol; 2017 Dec; 147(3):549-553. PubMed ID: 28942993
[TBL] [Abstract][Full Text] [Related]
27. Comparison between laparoscopic and robotic surgery for sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging.
Chaowawanit W; Campbell V; Wilson E; Chetty N; Perrin L; Jagasia N; Barry S
J Obstet Gynaecol; 2021 May; 41(4):642-646. PubMed ID: 32812452
[TBL] [Abstract][Full Text] [Related]
28. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
[TBL] [Abstract][Full Text] [Related]
29. A prospective evaluation of the sentinel node mapping algorithm in endometrial cancer and correlation of its performance against endometrial cancer risk subtypes.
Rajanbabu A; Agarwal R
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():77-80. PubMed ID: 29554604
[TBL] [Abstract][Full Text] [Related]
30. "Long-term outcome in endometrial cancer patients after robot-assisted laparoscopic surgery with sentinel lymph node mapping".
Jebens Nordskar N; Hagen B; V Vesterfjell E; Salvesen Ø; Aune G
Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():77-82. PubMed ID: 35151960
[TBL] [Abstract][Full Text] [Related]
31. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).
Altin D; Taşkın S; Kahramanoglu I; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Naki MM; Güngör M; Köse MF; Ortac F; Arvas M; Ayhan A; Taskiran C
Int J Gynecol Cancer; 2020 Jul; 30(7):1005-1011. PubMed ID: 32474451
[TBL] [Abstract][Full Text] [Related]
32. Reduced lymphedema after sentinel lymph node biopsy versus lymphadenectomy for endometrial cancer.
Glaser G; Dinoi G; Multinu F; Yost K; Al Hilli M; Larish A; Kumar A; McGree M; Weaver AL; Cheville A; Dowdy S; Mariani A
Int J Gynecol Cancer; 2021 Jan; 31(1):85-91. PubMed ID: 33243776
[TBL] [Abstract][Full Text] [Related]
33. Prospective study of sentinel lymph node mapping for endometrial cancer.
Togami S; Kawamura T; Fukuda M; Yanazume S; Kamio M; Kobayashi H
Int J Gynaecol Obstet; 2018 Dec; 143(3):313-318. PubMed ID: 30125949
[TBL] [Abstract][Full Text] [Related]
34. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?
Ye L; Li S; Lu W; He Q; Li Y; Li B; Wang X; Yan Q; Wan X
Oncologist; 2019 Dec; 24(12):e1381-e1387. PubMed ID: 31270269
[TBL] [Abstract][Full Text] [Related]
35. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
Siesto G; Romano F; Fiamengo B; Vitobello D
J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
[TBL] [Abstract][Full Text] [Related]
36. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
[TBL] [Abstract][Full Text] [Related]
37. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
Khoury-Collado F; St Clair C; Abu-Rustum NR
Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
[TBL] [Abstract][Full Text] [Related]
38. Controversies in Sentinel Lymph Node Biopsy for Gynecologic Malignancies.
Rossi EC; Tanner E
J Minim Invasive Gynecol; 2021 Mar; 28(3):409-417. PubMed ID: 33359741
[TBL] [Abstract][Full Text] [Related]
39. Sentinel node biopsy for the management of early stage endometrial cancer: long-term results of the SENTI-ENDO study.
Daraï E; Dubernard G; Bats AS; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Ballester M
Gynecol Oncol; 2015 Jan; 136(1):54-9. PubMed ID: 25450151
[TBL] [Abstract][Full Text] [Related]
40. [Application of the two-step sentinel lymph node biopsy with double-tracer in early staged endometrial cancer].
Wang YN; Xia YF; Chen YQ; Qi HY; Lou YH
Zhonghua Fu Chan Ke Za Zhi; 2022 Nov; 57(11):812-820. PubMed ID: 36456477
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]